{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T13:23:48Z","timestamp":1781184228390,"version":"3.54.1"},"reference-count":29,"publisher":"Pharmaceutical Society of Japan","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2019,11,1]]},"DOI":"10.1248\/bpb.b19-00394","type":"journal-article","created":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T22:03:41Z","timestamp":1567461821000},"page":"1867-1876","source":"Crossref","is-referenced-by-count":21,"title":["<i>N<\/i>-Linoleyltyrosine Protects against Transient Cerebral Ischemia in Gerbil <i>via<\/i> CB2 Receptor Involvement in PI3K\/Akt Signaling Pathway"],"prefix":"10.1248","volume":"42","author":[{"given":"Lin","family":"Cheng","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Chengdu Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Chengdu Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Research and Development Center, Chengdu Rongsheng Pharmaceuticals Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixue","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Chengdu Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ming","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Chengdu Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Chengdu Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) G\u00f3mez-Outes A, Su\u00e1rez-Gea ML, Garc\u00eda-Pinilla JM. When are the cardiovascular and stroke risks too high? Pharmacotherapy for stroke prophylaxis. Expert Opin. Pharmacother.<\/i>, 19<\/b>, 1427\u20131440 (2018).","DOI":"10.1080\/14656566.2018.1511703"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Eltzschig HK, Eckle T. Ischemia and reperfusion-from mechanimsm to translation. Nat. Med.<\/i>, 17<\/b>, 1391\u20131401 (2011).","DOI":"10.1038\/nm.2507"},{"key":"3","unstructured":"3) Arteaga O, Alvarez A, Revuelta M, Santaolalla F, Urtasun A, Hilario E. Role of antioxidants in neonatal hypoxic\u2013ischemia brain injury: new therapeutic approaches. Int. J. Mol. Sci.<\/i>, 18<\/b>, 265 (2017)."},{"key":"4","unstructured":"4) Krzy\u017canowska W, Pomierny B, Filip M, Pera J. Glutamate transporters in brain ischemia: to modulate or not? Acta Pharmacol. Sin.<\/i>, 35<\/b>, 444\u2013462 (2014)."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Jang IS, Park MY, Shin IW, Sohn JT, Lee HK, Chung YK. Ethyl pyruvate has anti-Inflammatory and delayed myocardial protective effects after regional ischemia\/reperfusion injury. Yonsei Med. J.<\/i>, 51<\/b>, 838\u2013844 (2010).","DOI":"10.3349\/ymj.2010.51.6.838"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Zhang M, Martin BR, Adler MW, Razdan RK, Ganea D, Tuma RF. Modulation of the balance between cannabinoid CB1 and CB2 receptor activation during cerebral ischemia\/reperfusion injury. Neuroscience<\/i>, 152<\/b>, 753\u2013760 (2008).","DOI":"10.1016\/j.neuroscience.2008.01.022"},{"key":"7","unstructured":"7) Willoughby KA, Moore SF, Martin BR, Ellis EF. The biodisposition and metabolism of anandamide in mice. J. Pharmacol. Exp. Ther.<\/i>, 282<\/b>, 243\u2013247 (1997)."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Lin Q, Hai J, Yao LY, Lu Y. Neuroprotective effects of NSTyr on cognitive function and neuronal plasticity in rats of chronic cerebral hypoperfusion. Brain Res.<\/i>, 1325<\/b>, 183\u2013190 (2010).","DOI":"10.1016\/j.brainres.2010.02.037"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Liu S, Tang SQ, Cui HJ, Yin S, Yin M, Zhao H, Meng LH, Wang ZJ, Lu Y. Dipotassium N<\/i>-stearoyltyrosinate ameliorated pathological injuries in triple-transgenic mouse model of Alzheimer\u2019s disease. J. Pharmacol. Sci.<\/i>, 132<\/b>, 92\u201399 (2016).","DOI":"10.1016\/j.jphs.2016.08.009"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Yao LY, Lin Q, Niu YY, Deng KM, Zhang JH, Lu Y. Synthesis of lipoamino acids and their activity against cerebral ischemic injury. Molecules<\/i>, 14<\/b>, 4051\u20134064 (2009).","DOI":"10.3390\/molecules14104051"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Yonkers KA. Polyunsaturated fatty acids, highly unsaturated fatty acids, and perinatal depression. Biol. Psychiatry<\/i>, 82<\/b>, 560\u2013569 (2017).","DOI":"10.1016\/j.biopsych.2017.02.1182"},{"key":"12","unstructured":"12) Haldar S, Karmakar K. A systematic understanding of gelation self-assembly: Solvophobically assisted supramolecular gelation via<\/i> conformational reorientation across amide functionality on a hydrophobically modulated dipeptide based ambidextrous gelator, N<\/i>-n<\/i>-acyl-(L)\u2013(I)Val-X(OBn), (X\u2009=\u20091, \u03c9-amino acid). RSC Advances<\/i>, 5<\/b>, 66339\u201366354 (2015)."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Barua CC, Haloi P, Saikia B, Sulakhiya K, Pathak DC, Tamuli S, Rizavi H, Ren X. Zanthoxylum alatum abrogates lipopolysaccharide-induced depression like behaviours in mice by modulating neuroinflammation and monoamine neurotransmitters in the hippocampus. Pharm. Biol.<\/i>, 56<\/b>, 245\u2013252 (2018).","DOI":"10.1080\/13880209.2017.1391298"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Luo Y, Tang H, Li H, Zhao R, Huang Q, Liu J. Recent advances in the development of neuroprotective agents and therapeutic targets in the treatment of cerebral ischemia. Eur. J. Med. Chem.<\/i>, 162<\/b>, 132\u2013146 (2019).","DOI":"10.1016\/j.ejmech.2018.11.014"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Kalogeris T, Baines CP, Krenz M, Korthuis RJ. Cell biology of ischemia\/reperfusion injury. Int. Rev. Cell Mol. Biol.<\/i>, 298<\/b>, 229\u2013317 (2012).","DOI":"10.1016\/B978-0-12-394309-5.00006-7"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Radenovic L, Selakovic V, Olivan S, Calvo AC, Rando A, Janac B, Osta R. Neuroprotective efficiency of tetanus toxin C fragment in model of global cerebral ischemia in Mongolian gerbils. Brain Res. Bull.<\/i>, 101<\/b>, 37\u201344 (2014).","DOI":"10.1016\/j.brainresbull.2013.11.006"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Berkowitz LE, Harvey RE, Drake E, Thompson SM, Clark BJ. Progressive impairment of directional and spatially precise tragectories by TgF344-Alzheimer\u2019s disease rats in the Morris Water Task. Sci. Rep.<\/i>, 8<\/b>, 16153 (2018).","DOI":"10.1038\/s41598-018-34368-w"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Johnson J Jr, Pajarillo EAB, Taka E, Reams R, Son DS, Aschner M, Lee E. Valproate and sodium butyrate attenuate manganese-decreased locomotor activity and astrocytic glutamate transporters expression in mice. Neurotoxicology<\/i>, 64<\/b>, 230\u2013239 (2018).","DOI":"10.1016\/j.neuro.2017.06.007"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Bao XQ, Li N, Wang T, Kong XC, Tai WJ, Sun H, Zhang D. FLZ alleviates the memory deficits in transgenic mouse model of alzheimer\u2019s disease via<\/i> decreasing beta-amyloid production and tau hyperphosphorylation. PLOS ONE<\/i>, 8<\/b>, e78033 (2013).","DOI":"10.1371\/journal.pone.0078033"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Pa\u013ea A, Schick J, Klein M, Mayer B, Schmitz B, Wirtz CR, Konig R, Kapapa T. The influence of nimodipine and vasopressors on outcome in patients with delayed cerebral ischemia after spontaneous subarachnoid hemorrhage. J. Neurosurg.<\/i>, 8<\/b>, 1\u20139 (2019).","DOI":"10.3171\/2018.11.JNS182891"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Li Y, Zhang T, Zhang X, Zou W, Gong X, Fu J. Cinepazide maleate improves cognitive function and protects hippocampal neurons in diabetic rats with chronic cerebral hypoperfusion. Biol. Pharm. Bull.<\/i>, 40<\/b>, 249\u2013255 (2017).","DOI":"10.1248\/bpb.b16-00567"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Hu W, Yang E, Ye J, Han W, Du Z. Resveratrol protects neuronal cells from isoflurane-induced inflammation and oxidative stress-associated death by attenuating apoptosis via<\/i> Akt\/p38 MAPK signaling. Exp. Ther. Med.<\/i>, 15<\/b>, 1568\u20131573 (2018).","DOI":"10.3892\/etm.2017.5527"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Al-Sayed E, Gad HA, El-Shazly M, Abdel-Daim MM, Nasser Singab A. Anti-inflammatory and analgesic activities of cupressuflavo from Cupressus macrocarpa<\/i> impact on pro-inflammatory mediators. Drug Dev. Res.<\/i>, 79<\/b>, 22\u201328 (2018).","DOI":"10.1002\/ddr.21417"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Bie B, Wu J, Foss JF, Naguib M. An overview of the cannabinoid type 2 receptor system and its therapeutic potential. Curr. Opin. Anaesthesiol.<\/i>, 31<\/b>, 407\u2013414 (2018).","DOI":"10.1097\/ACO.0000000000000616"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Su SH, Wang YQ, Wu YF, Wang DP, Lin Q, Hai J. Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via<\/i> PI3K\/AKT signaling. Behav. Brain Res.<\/i>, 313<\/b>, 334\u2013344 (2016).","DOI":"10.1016\/j.bbr.2016.07.009"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Cao Q, Liu X, Yang F, Wang H. CB2R induces a protective response for epileptic seizure via<\/i> the PI3K 110\u03b1-AKT signaling pathway. Exp. Ther. Med.<\/i>, 16<\/b>, 4784\u20134790 (2018).","DOI":"10.3892\/etm.2018.6788"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Fan L, Qiu XX, Zhu ZY, Lv JL, Lu J, Mao F, Zhu J, Wang JY, Guan XW, Chen J, Ren J, Ye JM, Zhao YH, Li J, Shen X. Nitazoxanide, an anti-parasitic drug, efficiently ameliorates learning and memory impairments in AD model mice. Acta Pharmacol. Sin.<\/i>, (2019).","DOI":"10.1038\/s41401-019-0220-1"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Lima IVA, Almeida-Santos AF, Ferreira-Vieira TH, Aguiar DC, Ribeiro FM, Campos AC, de Oliveira ACP. Antidepressant-like effect of valproic acid-possible involvement of PI3K\/Akt\/mTOR pathway. Behav. Brain Res.<\/i>, 329<\/b>, 166\u2013171 (2017).","DOI":"10.1016\/j.bbr.2017.04.015"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Esposito E, Cordaro M, Cuzzocrea S. Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury. Pharmacol. Res.<\/i>, 86<\/b>, 26\u201331 (2014).","DOI":"10.1016\/j.phrs.2014.05.009"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/42\/11\/42_b19-00394\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T03:21:43Z","timestamp":1572664903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/42\/11\/42_b19-00394\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,1]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b19-00394","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,1]]}}}